Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × Water × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 5 Colorectal Neoplasms 5 Neoplasms 4 Breast Neoplasms 4 Stomatitis 3 Neoplasm Metastasis 3 Adenoma 3 Urologic Neoplasms 2 Stomach Neoplasms 2 Mucositis 2 Insulin Resistance 2 Head and Neck Neoplasms 2 Vulvodynia 1 Urologic Diseases 1 Urolithiasis 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Skin Neoplasms 1 Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Pain, Postoperative 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Mobility Limitation 1 Melanoma 1 MRSA Colonization 1

Interventions

Morphine 15 Oxycodone 12 Methadone 7 Fentanyl 6 Lidocaine 5 Acetaminophen 5 nabiximols 4 Ethanol 4 resiniferatoxin 3 Transcutaneous Electric Nerve Stimulation 3 Hydromorphone 3 Buprenorphine 3 Acupuncture Therapy 3 Tapentadol 2 Surveys and Questionnaires 2 Standard of Care 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Ketamine 2 Control Groups 2 Analgesics, Opioid 2 tanezumab 1 rofecoxib 1 oxycodone naloxone combination 1 naloxegol 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 Water 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed

33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡